Paid Clinical Trials for Carcinoma, Non-Small Cell Lung

Showing all 5 results

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) – a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

in Carcinoma, Non-Small Cell Lung, Non Small Cell Lung Carcinoma, Non-Small Cell Lung Carcinoma, Non-small Cell Lung Cancer (NSCLC), Non Small Cell Lung Cancer

Other

Maryland

Deadline:

12/31/2034

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

by CTG

in HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, Esophageal Adenocarcinoma

Other

Alaska

Deadline:

03/22/2029

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

by CTG

in Carcinoma, Non-Small Cell Lung

Other

California

Deadline:

03/01/2029

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

by CTG

in Carcinoma, Non-Small Cell Lung

Other

Florida

Deadline:

12/02/2030

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

by CTG

in Non-Small Cell Lung Carcinoma, KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Non-small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung

Other

Massachusetts

Deadline:

05/18/2026

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) – a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Carcinoma, Non-Small Cell Lung

Filter Results:

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) – a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps